Mottola Frank
SVP, Chief Tech. Ops. Officer · 19 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-09 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sale | 1,623 | $53.65 | $87,073.95 | filing |
| 2026-03-06 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Tax withholding | 1,793 | $54.73 | $98,130.89 | filing |
| 2026-03-06 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Option exercise | 3,750 | $0.00 | $0.00 | filing |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Tax withholding | 977 | $50.69 | $49,524.13 | filing |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Award | 1,875 | $0.00 | $0.00 | filing |
| 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Tax withholding | 670 | $50.86 | $34,076.20 | filing |
| 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Tax withholding | 603 | $51.35 | $30,964.05 | filing |
| 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Tax withholding | 368 | $50.86 | $18,716.48 | filing |
| 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Award | 1,250 | $0.00 | $0.00 | filing |
| 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Award | 1,125 | $0.00 | $0.00 | filing |
| 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Award | 750 | $0.00 | $0.00 | filing |
| 2025-12-19 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sale | 15,000 | $50.47 | $757,050.00 | filing |
| 2025-12-19 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Option exercise | 15,000 | $25.30 | $379,500.00 | filing |
| 2025-12-19 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sale | 5,000 | $50.22 | $251,100.00 | filing |
| 2025-12-19 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Option exercise | 5,000 | $39.40 | $197,000.00 | filing |
| 2025-09-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sale | 5,000 | $45.87 | $229,350.00 | filing |
| 2025-09-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Option exercise | 5,000 | $39.40 | $197,000.00 | filing |
| 2025-08-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sale | 14,000 | $44.51 | $623,140.00 | filing |
| 2025-08-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Option exercise | 14,000 | $12.98 | $181,720.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.